Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis.
This meta-analysis of four low-quality studies found that micronized palmitoylethanolamide/trans-polydatin improved chronic pelvic pain and dysmenorrhea in endometriosis patients, but had limited effect on deep dyspareunia and no effect on dyschezia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (6)
- Resveratrol and Its Natural Analogs Mitigate Immune Dysregulation and Oxidative Imbalance in the Endometriosis Niche Simulated in a Co-Culture System of Endometriotic Cells and Macrophages 2024
- Neuroproliferative dyspareunia in endometriosis and vestibulodynia 2023
- Nutritional Interventions, Complementary and Alternative Medicine for Endometriosis 2022
- Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain 2021
- Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets? 2021
- Is Scientific Medical Literature Related to Endometriosis Treatment Evidence-Based? A Systematic Review on Methodological Quality of Randomized Clinical Trials 2019
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:25.745717+00:00